The 8 Most Common (and Costly!) Life Cycle Management Pitfalls (and How to Avoid Them)

RxC International Life Cycle Management Pitfalls.jpg

Common life cycle pitfallscan lead to sub-optimal life cycle plans or ineffective implementations.  Companies that don’t optimize the life cycle management process and develop innovative strategies to meet the demands of today’s pharmaceutical landscape generally experience lower returns than their more proactive counterparts.

How to Avoid Pharmaceutical Value Erosion: 5 Critical Components of a Highly Effective Life Cycle Management Process

A comprehensive Life Cycle Management (LCM) process is essential to developing pharmaceutical life cycle plans that deliver maximum value over the life of pipeline and marketed products. Ensuring that the life cycle process is objectively and consistently executed enables organizations to fully explore all potential concepts, foster collaborative thinking, and uncover more innovative opportunities. Life sciences companies with multiple products across several therapeutic areas can benefit from a consistent approach that allows management to make effective comparisons across the organizational portfolio and allocate resources accordingly.

The Importance of Early Life Cycle Management

Companies must implement effective Life Cycle Management (LCM) strategies to build more value into products while they are still in development.  LCM includes identifying and prioritizing multiple potential indications and formulations while strategically planning their development and launch timing and sequence. Competitive companies must also direct sufficient resources to a strong LCM process for their pipeline and marketed products.

RxC Life Cycle Management Case Studies

rxC Life Cycle Strategy

Specialty Product Strategy

RxC Target Value Profile

Target Value Profile for a New Drug

RxC Market Potential of a Phase 3 Drug

Market Potential of a Phase 3 Drug

External Resources